About Merge
Merge is a leading provider of clinical systems and innovations that seek to transform healthcare. Merge's enterprise and cloud-based solutions for image intensive specialties provide access to any image, anywhere, any time. Merge also provides clinical trials software and other health data and analytics solutions that engage consumers in their personal health. With solutions that are used by providers and consumers and include more than 25 years of innovation, Merge is helping to reduce costs and improve the quality of healthcare worldwide. For more information, visit merge.com.
About Advanced Data Systems (ADS)
Ad Statistics
Times Displayed: 50320
Times Visited: 1434 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
Advanced Data Systems (ADS) is a leading provider of interoperable automation solutions to imaging centers, medical practices, behavioral health practices, and to revenue cycle management companies. The Medics Suite from ADS includes MedicsDocAssistant (version 7.0 is certified by ICSA Labs™ as a complete EHR for Stage 2 Meaningful Use), MedicsPremier™ and MedicsElite™ for comprehensive practice management, and MedicsRIS™ for radiology. The Medics Suite is integrated as a unified solution or can be obtained separately per the needs of the practice. They can be utilized in Cloud / ASP format or Client Server (customer hosted) formats. ADS provides quick Implementation, comprehensive Training and excellent ongoing Support with Updates. Thousands of providers rely on solutions from ADS.
Cautionary Notice Regarding Forward-Looking Statements
The matters discussed in this news release may include forward-looking statements, which could involve a number of risks and uncertainties. When used in this press release, the words "will," "believes," "intends," "anticipates," "expects" and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by such forward-looking statements. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements.
Back to HCB News
